r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

KB

Kevin Bitterman

Insider · Director · IRON

Kevin Bitterman files insider transactions with the SEC as a director of Disc Medicine (IRON). We hold 3 disclosed purchases and sales filed since 11 February 2014, 3 of them in the last 90 days.

  • Files forIRON
  • Disclosed buys and sells3 in all, 3 in the last 90 days
  • Last disclosure3 September 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 29 December 2022 — 3 September 2026Director · Disc Medicine (IRON)90 Form 4 lines · source: SEC Form 4
  • Filed 24 June 2019 — 1 June 2021Director · Akero Therapeutics (AKRO)11 Form 4 lines · source: SEC Form 4
  • Filed 8 February 2016 — 15 June 2017Director · Editas Medicine (EDIT)18 Form 4 lines · source: SEC Form 4
  • Filed 10 February 2014 — 7 June 2016Director · Genocea Biosciences (GNCA)13 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.